Teva Receives FDA Approval for Generic Zoloft(R) Tablets (Business Wire via Yahoo! Finance)
JERUSALEM----June 30, 2006--Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application to market its generic version of Pfizer's Zoloft Tablets, 25 mg, 50 mg, and 100 mg.

Oscient Pharmaceuticals Announces Meeting Date for FDA Advisory Committee to Address sNDA for Five-Day Treatment of (Business Wire via Yahoo! Finance)
WALTHAM, Mass.----June 28, 2006--The U.S. Food and Drug Administration has informed Oscient Pharmaceuticals Corporation that the FDA's Anti-Infective Drugs Advisory Committee will review the supplemental New Drug Application for FACTIVE tablets for the treatment of acute bacterial sinusitis on September 12, 2006.